Difference between revisions of "Team:CSMU Taiwan/Human Practices"

Line 249: Line 249:
 
                                 <div class="ModalDescription">
 
                                 <div class="ModalDescription">
 
                                     <h1>Form</h1>
 
                                     <h1>Form</h1>
                                     <h1>Form</h1>
+
                                     We had an interview with Doctor Yuan-Yen, Chang on March 20th at Chung-Shan Medical University. Doctor Chang is the professor of microbiology. His specialties are virology, Immunology, and biotechnology.
Our team had an interview with Ph.D. Chih-Ming Chen, who is the Senior Director of the Business Development of TaiGen Biotechnology.
+
                                    <h1>Purpose</h1>
<h1>Purpose</h1>
+
                                    As a professor of microbiology, doctor Chang knows well about the knowledge as well as the mechanism of respiratory disease. Through this interview, we would like to know more about the background knowledge of respiratory disease and the diagnosis of influenza. We drafted the questions below:
Through the interview, we would like to know if it’s possible to develop a medicine with aptamers and understand the market of influenza medicine nowadays. We drafted the questions below:
+
                                    <ul>
<ul>
+
                                        <li>How to detect influenza in a lab?</li>
 
+
                                        <li>What kind of sample does the professor recommend for influenza rapid test? </li>
<li>What is the mechanism of your(TaiGen) new influenza medicine—TG1000? How does it function as a medicine and a vaccine at the same time? </li>
+
                                        <li>Do you recommend using the blood to detect the flu directly? </li>
<li>In the industry of influenza medicine, what aspect do the biotechnology companies focus on? What is the present situation of the influenza market? Why does TaiGen choose influenza as the subject to develop? </li>
+
                                        <li>Do you recommend using swabs to detect flu directly? </li>
<li>How do biotechnology companies estimate the potential and prospect of a newly developed product? What aspect should be noticed? </li>
+
                                        <li>What are the current methods of influenza detection? </li>
<li>Can aptamers be applied to medicine? </li>
+
                                        <li>Do you have any suggestions for our fast screening products? </li>
</ul>
+
                                    </ul>
<h1>Process</h1>
+
                                    <h1>Process</h1>
<ul>
+
                                    <ul>
<li>Mr. Chen said that the mechanism of their new medicine—TG-1000 is Cap-snatching. It inhibits the duplication of influenza viruses and has shown well result on animal tests. It resists Type A and B and avian influenza H7N9 infection. Moreover, the validity period of the medicine lasts for 72 hours, which is better than Tamiflu. There isn’t only one molecule of the virus in one cell, so medicines have to reach a certain concentration to have a function. The viral molecules will combine with the medicine through random collision. By measuring the medicine's inhibition constant (IC50) or so-called binding constant can let us know their affinity to viruses. </li>
+
                                        <li>Generally, a bacterial culture is performed in a lab, and the whole process takes about 3 to 7 days. </li>
<li>The influenza virus often infects lung cells, however, the concentration of the medicine in the blood doesn’t represent the same as in the lung. It is important to prove that the concentration in both places is proportional. Also, confirming that whether the medicine can exactly achieve the goal is very important. </li>
+
                                        <li>The general influenza samples have two forms, blood, and swab. The advantage of a blood sample is a lot amount at one time. The advantage of the swab is non-invasive. </li>
<li>The product is design as an oral medicine for easier taking in. Different diseases have different consideration, for example, intravenous injection make medicine spread faster in body but oral medicine is more convenient for patients to take in. </li>
+
                                        <li>Dr. Chang recommended swab as the sample of our influenza rapid test. Since taking a blood sample needs to penetrate patients’ skin with needles, it is more invasive than taking a swab sample and less accepted by patients. Besides, drawing blood can only be conducted by professionally trained people, it isn’t good for promoting simple use. What’s more, a blood sample is valid only when there is viruses in the blood, or so-called viremia. </li>
<li>Besides providing community immunity, the advantage of their product is its slow metabolism rate. It keeps the effect even longer than a week, so it doesn’t need to be taken earlier before infection like a vaccine, and the effect is also much better than the vaccine. </li>
+
                                        <li>Dr. Chang recommended that we design a kit that can test lots of pathogens and is user-friendly, which means everyone, even people who aren’t professionally trained, can use it. To know more about the technique he suggested we visit Adimmune Corporation. </li>
<li>The limitation of the medicine is that the safety range of the dosage is narrow. If a child showed resistance to some other flu medicine, doctors can’t increase the dosage for the concern of safety. Although TG100 hasn’t passed a human test, the result of an animal test showed that the dosage can be increased. </li>
+
                                    </ul>
<li>The reason why they choose to develop influenza medicine is that there are 3 to 5 million people affected by influenza annually, and Tamiflu, the flu medicine most commonly used, has many limitations needed to be improved. </li>
+
                                    <h1>Feedback</h1>
<li>If technology advanced more in the future, it is possible to design an antibody by just knowing the structure of the protein of a virus. With gene sequencing, we are able to compare the similarity between different viruses similar and apply the same medicine to similar ones, which reduces the cost of the process to develop new medicines. </li>  
+
                                    After the interview, we had a clearer idea of our product. We decided to take swabs as the sample of our device. Our device needs to be fast, accurate and easy-to-use. We can make our product as kits in the near future, and we can ask Adimmune Corporation for more details.
<li>As for applying aptamer to medicine, Mr. Chen agreed with our idea. He said medicine is not restricted to only a specific type. He emphasized that collecting data is very important. </li>
+
</ul>
+
<h1>Feedback</h1>
+
Through this interview, we got a lot of information about developing medicine. Besides, we knew more about the defects of influenza medicine nowadays. The importance of developing better medicine for influenza is worth noticing. Mr. Chen gave us a positive answer to our concept of applying aptamer to treatment. We then came up with the idea of applying aptamers to preventive medicine.
+
  
  

Revision as of 05:38, 17 October 2019

Stack Multipurpose HTML Template

Human Practice structure

Participatory Design (PD)

Participatory Design is an emerging design practice which involves different non-designers in various co-design activities throughout the process, to help ensure that the designed product/service meets their needs.

In participatory design members of the wider community are also recognized as stakeholders which are able to impact the project. The extent of their involvement can range from being passively informed of a project’s development, to actively sharing their opinions in decision making.

What

Design for humans is often looked up as a standard by many designers, but how is it for people? Market research, focus group, usability testing, and other research methods are useful but sometimes they don't let us know the really important feedback. Sometimes users don't honestly say their ideas because of courtesy. More often users don't really know what they want or what they need, or the emotional level of them is often not quantifiable.

Design with Human is a part of participatory design, bringing users into the design process, in order to understand the psychological or social aspects of the user's ideas or use in the early stages of product development. Use Cases to work together to design a solution.

Why

Designers are not users, neither are product managers nor engineers. In the process of current software development, software often involves or affects various user cultural, political or psychological factors. The knowledge that a product development team needs is not just the product development team itself, but the idea of different aspects and different fields to inspire the best solution.
Imagine that in the process of traditional product design, a product team which lacks a real understanding of the user's needs is given a goal to solve a problem, the design made at this time may not really solve the user's problem, or become a mediocre product. Usually, it becomes Product Manager Driven instead of User-Driven .
Participatory design< gives users an opportunity to participate in the design. However, it is important to know that the users involved in the design do not influence the final product development decisions. Also, they do not have the professional knowledge as the product development team to understand the operation and execution of the entire product.

How

Participatory design is used in various design fields, include industrial design, architectural design, software design, and etc. In fact, there is not a specific way to make a participatory research session, that is, the simpler the better.
Back to our team, in order to expand our influences and to make sure all our human practice activities reach their maximum efficiencies and values, we 1) evaluate who our potential stakeholders are and make sure they participated in our project design, inspiring product modifies to made final product better-fit user’s needs.2) took the research of Sanders, E. B.-N., Brandt, E., & Binder, T. (2010). “A framework for organizing the tools and techniques of participatory design.” as a reference and developed a systematic structure to help us designing activities for human practice and public engagement, it includes three key points:

  1. Applying with an appropriate Form
  2. Adhering to core principle or Purpose
  3. Designing a suitable Process
  4. Learing from Feedbacks
Furthermore, it involved stakeholders from different aspects of our product. Through this systematic structure, we can not only programmatically arrange our activities but also examine the effectiveness of them. We introduced it to our human practice even public engagement. We hope that aside from us, future iGEM teams can also set up their own concept on this foundation.

Form

It describes the conducted time, the kind of the activity that is taking place and how it is been held. For different purpose, there will have different places and ways which is most suitable for the activities. Participatory design sessions can be conducted with either individuals or with people in groups. We classified the forms of our activities into individual, one-to-one interviews, and groups.

Purpose

According to the designation of PD, we came up with three main principle that may be introduced to different activities:

  1. to stimulate participants interest,
  2. to let the participants gain information
  3. to discuss with the participants and let them generate ideas.
Moreover, we will set up a goal for each activity that might either benefit our study or can affect the public.

Process

It includes the detail of the designation of the activities or the document of what the participants do or said without judgment.

Feedbacks

It is an important part for us to realize what the participants think about. We collected the opinions, suggestions, and even encouragements from the participants which is precious to our study and even other sides of our personal abilities. We think that each activity can affect both conductors and participants. We also recorded our thoughts and what we gain from the activities.

References

  1. Sanders, E. B.-N., Brandt, E., & Binder, T. (2010). A framework for organizing the tools and techniques of participatory design. PDC '10 Proceedings of the 11th Biennial Participatory Design Conference, Pages 195-198 https://dl.acm.org/citation.cfm?id=1900476 https://sci-hub.tw/10.1145/1900441.1900476
  2. Participate in Design (P!D) http://participateindesign.org/about/organisation
  3. Liz Sanders, An Evolving Map of Design Practice and Design Research, 2008
  4. Ines Anić, Participatory Design: What is it, and what makes it so great?, 2015
  • 14th, March

  • Doctor Hui-Xian Pan, Pediatrician

  • We found the importance of developing a rapid influenza diagnostic test with higher sensitivity and accuracy to help doctors make the best diagnosis and help the government for the statistics of epidemiology.

Twelve different integrated stress reporters allow for extensive and easy high-throughput screening of candidate compounds
Twelve different integrated stress reporters allow for extensive and easy high-throughput screening of candidate compounds
Twelve different integrated stress reporters allow for extensive and easy high-throughput screening of candidate compounds
Twelve different integrated stress reporters allow for extensive and easy high-throughput screening of candidate compounds
Twelve different integrated stress reporters allow for extensive and easy high-throughput screening of candidate compounds
Twelve different integrated stress reporters allow for extensive and easy high-throughput screening of candidate compounds
Twelve different integrated stress reporters allow for extensive and easy high-throughput screening of candidate compounds
Twelve different integrated stress reporters allow for extensive and easy high-throughput screening of candidate compounds
Twelve different integrated stress reporters allow for extensive and easy high-throughput screening of candidate compounds
Twelve different integrated stress reporters allow for extensive and easy high-throughput screening of candidate compounds
Twelve different integrated stress reporters allow for extensive and easy high-throughput screening of candidate compounds
Twelve different integrated stress reporters allow for extensive and easy high-throughput screening of candidate compounds
Twelve different integrated stress reporters allow for extensive and easy high-throughput screening of candidate compounds
Twelve different integrated stress reporters allow for extensive and easy high-throughput screening of candidate compounds
Twelve different integrated stress reporters allow for extensive and easy high-throughput screening of candidate compounds
Twelve different integrated stress reporters allow for extensive and easy high-throughput screening of candidate compounds
Twelve different integrated stress reporters allow for extensive and easy high-throughput screening of candidate compounds

Charlotte de Ceuninck van Capelle

Team manager

Daphne van den Homberg

Secretary & Design manager

Maaike de Jong

Treasurer